Literature DB >> 225025

Influence of adrenal corticosteroids on the susceptibility of cats to feline leukemia virus infection.

J L Rojko, E A Hoover, L E Mathes, S Krakowka, R G Olsen.   

Abstract

The natural resistance of adult specific-pathogen-free cats to feline leukemia virus (FeLV) was abrogated by treatment with various doses of a synthetic corticosteroid, methylprednisolone acetate (MPA), prior to either oral-nasal or i.p. inoculation of FeLV. Persistent viremia was induced in 82% (18 of 22) of MPA-treated cats versus 11% (1 of 9) of age-matched control cats. MPA-treated FeLV-inoculated cats developed prolonged lymphopenia (2 to 8 weeks postinoculation) and a delayed antibody response to the feline oncornavirus-associated cell membrane antigen. The distribution of FeLV group specific antigen in tissues of MPA-treated, FeLV-inoculated cats suggested that corticosteroids enhanced susceptibility to FeLV by impairing early viral containment in the reticuloendothelial and lymphoid tissues.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 225025

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Effects of cobra venom factor treatment on latent feline leukemia virus infection.

Authors:  E H Kraut; J L Rojko; R G Olsen; D L Tuomari
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

Review 2.  Immunopathology induced by the feline leukemia virus.

Authors:  W D Hardy
Journal:  Springer Semin Immunopathol       Date:  1982

3.  Fecal Glucocorticoid Metabolites as a Noninvasive Indicator of Stress in the Tsushima Leopard Cats (Prionailurus bengalensis euptilurus): Application to Health Care.

Authors:  Satoshi Kusuda; Takashi Funahashi; Itsuki Adachi; Hanae Yamamoto; Eiji Nagao; Kirito Matsui; Yuki Akiba
Journal:  Animals (Basel)       Date:  2022-04-21       Impact factor: 3.231

Review 4.  Endogenous env elements: partners in generation of pathogenic feline leukemia viruses.

Authors:  P Roy-Burman
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

5.  Protection against feline leukemia by vaccination with a subunit vaccine.

Authors:  M G Lewis; L E Mathes; R G Olsen
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

6.  Broadening the use of antiretroviral therapy: the case for feline leukemia virus.

Authors:  Willie M Greggs; Christine L Clouser; Steven E Patterson; Louis M Mansky
Journal:  Ther Clin Risk Manag       Date:  2011-03-16       Impact factor: 2.423

Review 7.  A Retrospective Examination of Feline Leukemia Subgroup Characterization: Viral Interference Assays to Deep Sequencing.

Authors:  Elliott S Chiu; Edward A Hoover; Sue VandeWoude
Journal:  Viruses       Date:  2018-01-10       Impact factor: 5.048

Review 8.  Feline leukemia/sarcoma viruses and immunodeficiency.

Authors:  J Rojko; M Essex; Z Trainin
Journal:  Adv Vet Sci Comp Med       Date:  1988

9.  Immunogenicity and efficacy of a commercial feline leukemia virus vaccine.

Authors:  N C Pedersen
Journal:  J Vet Intern Med       Date:  1993 Jan-Feb       Impact factor: 3.333

Review 10.  The immunobiology of the feline leukemia virus.

Authors:  J L Rojko; R G Olsen
Journal:  Vet Immunol Immunopathol       Date:  1984-05       Impact factor: 2.046

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.